Wednesday, May 25, 2022, 12:45 PM - 2:00 PM
The AQC recognizes the biopharmaceutical industry cannot elevate quality to the highest levels without addressing how Diversity, Equity, and Inclusion elements can be incorporated into trial design. The clinical trial industry has not yet determined all of the right levers to pull. In this session Dr. Crissy MacDonald, WCG Avoca Vice President of Client Delivery, will facilitate a discussion aimed at identifying the current challenges and barriers to creating a more inclusive clinical trial and how “rethinking & relearning” can assist in the development of a more scalable, cost-effective solutions to engage more diverse patient populations.
